Concentra Group Holdings Parent, Inc. (CON) - 10-K Summary
Business Context and Reporting Period
Company: Concentra Group Holdings Parent, Inc.
Reporting Period: Fiscal Year Ended December 31, 2024
Business Overview: Concentra is the largest provider of occupational health services in the United States by number of locations. As of December 31, 2024, the company operated 552 stand-alone occupational health centers in 41 states and 157 onsite health clinics in 36 states. Services include workers' compensation injury care, employer services (physicals, drug screening), and consumer health services.
Significant Event: The company completed its Initial Public Offering (IPO) on July 26, 2024, and separated from its former parent, Select Medical Holdings Corporation, via a spin-off distribution on November 25, 2024.
Key Financial Metrics
| Metric | 2024 | 2023 |
|---|---|---|
| Revenue | $1,900.2 million | $1,838.1 million |
| Net Income (GAAP) | $171.9 million | $184.7 million |
| Net Income Attributable to Company | $166.5 million | $179.9 million |
| Adjusted EBITDA | $376.9 million | $361.3 million |
| Adjusted EBITDA Margin | 19.8% | 19.7% |
| Operating Cash Flow | $274.7 million | $234.3 million |
| Total Debt (Principal) | $1,503.4 million | $474.7 million |
| Cash and Equivalents | $183.3 million | $31.4 million |
| Revolving Credit Availability | $386.4 million | N/A (Related party note) |
Material Changes vs. Prior Period
- Revenue Growth: Revenue increased 3.4% to $1,900.2 million, driven primarily by a 4.5% increase in revenue per visit ($141.30 vs. $135.22). This was partially offset by a 1.2% decrease in total patient visits (12.6 million vs. 12.8 million), specifically a 4.8% decline in employer services visits.
- Profitability: Net income decreased 7.0% to $171.9 million. The decline was primarily due to a significant increase in interest expense ($47.7 million in 2024 vs. $0.2 million in 2023) resulting from new debt financing incurred in connection with the IPO and separation. Operating income increased 6.0% to $304.8 million.
- Capital Structure: The company transitioned from related-party debt to public capital markets. In July 2024, it issued $650.0 million in 6.875% Senior Notes due 2032 and established a $1,250.0 million credit facility ($850.0 million term loan and $400.0 million revolver). Proceeds were used to repay related-party debt and fund a dividend to Select Medical.
- Cost Structure: Cost of services remained stable at 72.2% of revenue. General and administrative expenses increased slightly to 8.2% of revenue, now including separation transaction costs and acquisition costs.
Guidance, Outlook, and Risks
Outlook and Strategy: Management focuses on organic growth through same-center visit volume and strategic acquisitions. The company recently announced the acquisition of Nova Medical Centers (effective March 1, 2025) for $265 million, which will expand its footprint to over 775 centers. The company declared a quarterly cash dividend of $0.0625 per share in February 2025.
Key Risks and Contingencies:
- Regulatory and Legal: The company faces ongoing investigations regarding billing and coding for physical therapy claims by the U.S. Department of Justice and the California Department of Insurance. Additionally, the company is subject to extensive federal and state healthcare regulations, including the Anti-Kickback Statute and Stark Law.
- Cybersecurity: The company experienced a data breach involving a third-party vendor (Perry Johnson & Associates) in late 2023 affecting nearly four million patients, resulting in consolidated class action litigation.
- Separation Risks: As a newly independent public company, Concentra faces risks related to establishing standalone corporate functions, potential increases in operating costs, and reliance on transition services from Select Medical.
- Reimbursement Rates: Revenue is heavily dependent on state workers' compensation fee schedules. Failure to realize reimbursement increases sufficient to keep pace with inflation could adversely affect margins.
Investor Verification Checklist
- Debt Covenants: Verify compliance with the new Credit Agreement leverage ratio (currently 3.46x, limit 6.50x) and the impact of the recent Nova acquisition on future leverage.
- Legal Exposure: Monitor the status and potential financial impact of the DOJ and California Department of Insurance investigations into physical therapy billing practices.
- Cybersecurity Litigation: Track the progression of the consolidated class action lawsuits stemming from the Perry Johnson & Associates data breach.
- Reimbursement Trends: Analyze state-by-state fee schedule changes to assess the sustainability of the 4.5% revenue-per-visit growth rate.
- Integration Costs: Review the actual costs incurred to establish standalone corporate functions post-separation versus the estimates provided in the filing.